India uses Alzumab-L Itolizumab from Bioncon, India – this is a monoclonal antibody compound.


In the U.S. monoclonal antibody has been approved by the FDA for EUA (Emergency Use Authorization). Two compounds used in the U.S. are listed below.

bamlanivimab and etesevimab made by Lilly (a pharma company)

casirivimab and imdevimab, trade name: REGN-COV2 and made by Regeneron Pharmaceuticals

Leave a Reply

Your email address will not be published. Required fields are marked *